Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Kissei licenses antidiabetic agent to Purdue

May 8, 1997

Genentech enters into agreement for embryonic stem cell renewal factor

May 8, 1997

Senetek seeks European approval of erectile dysfunction therapy

May 8, 1997

DEA recommends descheduling of Redux

May 7, 1997

Fosamax cleared as preventive medication in osteoporosis

May 7, 1997

Gene Logic and Johns Hopkins University enter into research collaboration

May 7, 1997

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

Positive clinical results for amylin analogue in diabetes

May 7, 1997

Combined blockade of 5-HT1A and 5-HT1B receptors potentiates fluoxetine activity

May 7, 1997

Neuromyalgic response to rhNGF described

May 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...